Skip to Main Content

Author Details

Maria E Sundaram
Dalla Lana School of Public Health, University of Toronto
2012
59
21
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37963353Incorporating Efficacy Data from Initial Trials Into Subsequent Evaluations: Application to Vaccines Against Respiratory Syncytial Virus.Epidemiology2024
36400661COVID-19 vaccine coverage disparities in rural and farm children.Vaccine2023
37611032Comparison of socio-economic determinants of COVID-19 testing and positivity in Canada: A multi-provincial analysis.PLoS One2023
37034783Incorporating efficacy data from initial trials into subsequent evaluations: Application to vaccines against respiratory syncytial virus.medRxiv2023
36999905Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate?Clin Infect Dis2023
35201285Rare Sudden Sensorineural Hearing Loss Potentially Associated With COVID-19 Vaccination Does Not Outweigh the Benefit of COVID-19 Vaccines.JAMA Otolaryngol Head Neck Surg2022
35611399Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2.Influenza Other Respir Viruses2022
35728989Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.Vaccine2022
35718390Toward a Deeper Understanding of the Spectrum of Parental Human Papillomavirus Vaccine Hesitancy.J Adolesc Health2022
36577134Extended surveillance to assess safety of 9-valent human papillomavirus vaccine.Hum Vaccin Immunother2022
36147595Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study.Open Forum Infect Dis2022
36244366Prioritisation of COVID-19 boosters in the omicron era.Lancet2022
35132198Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario.Nat Microbiol2022
35256221Supporting individual vaccine decision-making: A role for vaccination counselors.Vaccine2022
34859584Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.Influenza Other Respir Viruses2022
34949496The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.Vaccine2022
35202783Stringency of containment and closures on the growth of SARS-CoV-2 in Canada prior to accelerated vaccine roll-out.Int J Infect Dis2022
32415521Young Adult Human Papillomavirus and Influenza Vaccine Coverage: A Comparison Across College Enrollment Status.J Community Health2021
36098108Racial disparities in influenza vaccination.Lancet Healthy Longev2021
33906966Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.CMAJ2021
34921078Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study.BMJ Open2021
34417165Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.BMJ2021
34145437Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.Nat Med2021
34373124Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.Vaccine2021
33411792Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations.PLoS One2021
32637976Social determinants of COVID-19 mortality at the county level.medRxiv2020
33223309Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt.Vaccine2020
33052932Social determinants of COVID-19 mortality at the county level.PLoS One2020
33398304Kinetics of antibody responses dictate COVID-19 outcome.medRxiv2020
31537322Evidence of Background Checks in an Online Firearms Marketplace.Am J Prev Med2019
29053189Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.J Med Virol2018
29803270Comparing Reported Dietary Supplement Intakes between Two 24-Hour Recall Methods: The Automated Self-Administered 24-Hour Dietary Assessment Tool and the Interview-Administered Automated Multiple Pass Method.J Acad Nutr Diet2018
28665726Epidemiologic Investigation of Highly Pathogenic H5N2 Avian Influenza Among Upper Midwest U.S. Turkey Farms, 2015.Avian Dis2017
28752133Comparison of recruitment and retention among demographic subgroups in a large diverse population study of diet.Contemp Clin Trials Commun2017
28562111Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Expert Rev Vaccines2017
27020709HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2014.Vaccine2016
26334765Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes.J Med Virol2016
27980605Early newborn ritual foods correlate with delayed breastfeeding initiation in rural Bangladesh.Int Breastfeed J2016
27203211Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells.Oncotarget2016
27419158Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons.Open Forum Infect Dis2016
27571905Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.J Infect Dis2016
27061888Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.Lancet Infect Dis2016
24962752Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.Vaccine2015
26380344Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.Open Forum Infect Dis2015
25903659Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.BMC Infect Dis2015
25964261Comparison of Interviewer-Administered and Automated Self-Administered 24-Hour Dietary Recalls in 3 Diverse Integrated Health Systems.Am J Epidemiol2015
25406334Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.J Infect Dis2015
24265361Medically attended respiratory syncytial virus infections in adults aged â¿¥ 50 years: clinical characteristics and outcomes.Clin Infect Dis2014
25270645Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons.Clin Infect Dis2014
25025344Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults â¿¥50 years old.PLoS One2014
  • 1 - 50 of 59

Recommended Authors

Centers for Disease Control and Prevention
Career Start Year 2018
Number of shared co-authors 7
College of Public Health and Health Professions, University of Florida
Career Start Year 2017
Number of shared co-authors 6
Yale University School of Public Health, 60 College St
Career Start Year 2017
Number of shared co-authors 22
College of Public Health and Health Professions, University of Florida
Career Start Year 2015
Number of shared co-authors 4
US Centers for Disease Control and Prevention
Career Start Year 2014
Number of shared co-authors 5
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
Nationwide Children's Hospital Columbus
Career Start Year 2012
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2012
Number of shared co-authors 11
Columbia University Vagelos College of Physicians and Surgeons.
Career Start Year 2011
Number of shared co-authors 5
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 10
University of Washington
Career Start Year 2010
Number of shared co-authors 0
NewYork-Presbyterian Hospital
Career Start Year 2007
Number of shared co-authors 8
Children's Hospital Colorado, University of Colorado School of Medicine
Career Start Year 2007
Number of shared co-authors 2
University of Michigan School of Public Health ann arbor
Career Start Year 2006
Number of shared co-authors 11
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 12
Centers for Disease Control and Prevention
Career Start Year 2005
Number of shared co-authors 10
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 4
University of Florida
Career Start Year 2004
Number of shared co-authors 8
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 12
U.S. Centers for Disease Control and Prevention
Career Start Year 2002
Number of shared co-authors 11
Centers for Disease Control and Prevention
Career Start Year 2001
Number of shared co-authors 10
Centers for Disease Control and Prevention
Career Start Year 2000
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 2000
Number of shared co-authors 5
Clalit Health Services, Ben Gurion University
Career Start Year 1998
Number of shared co-authors 3
Centers for Disease Control and Prevention
Career Start Year 1995
Number of shared co-authors 8
University of Washington, Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 5
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 2

Collaborators

Marshfield Clinic Research Institute
Co-authored papers 18
Marshfield Clinic Research Institute, Marshfield Clinic Health System
Co-authored papers 12
Yale School of Public Health
Co-authored papers 5
Vanderbilt University Medical Center
Co-authored papers 4
Vanderbilt University Medical Center
Co-authored papers 4
Marshfield Clinic Research Institute
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
University of Pittsburgh
Co-authored papers 3
Centers for Disease Control and Prevention
Co-authored papers 2
Yale University
Co-authored papers 2
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Baylor Scott & White Research Institute
Co-authored papers 2
School of Public Health, Yale University
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Christian Medical College
Co-authored papers 2
University of California
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 2
Center for Vaccines and Immunology, University of Georgia
Co-authored papers 2
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Marshfield Clinic Research Institute
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale University
Co-authored papers 2